Animal Health
Veterinary Parasiticides Market

Veterinary Parasiticides Market Size, Share, and Growth Forecast 2026 - 2033

Veterinary Parasiticides Market by Animal Type (Production Animal, Companion Animal), by Product (Ectoparasiticides, Endoparasiticides, Endectocides), by Route of Administration (Oral, Injectable, Topical), by Regional Analysis, 2026 - 2033

ID: PMRREP34751

March 2026

204 Pages

Author : Pravin Rewale

Healthcare

Veterinary Parasiticides Market Size and Trend Analysis

The global veterinary parasiticides market size is expected to be valued at US$ 10.9 billion in 2026 and projected to reach US$ 17.1 billion by 2033, growing at a CAGR of 6.7% between 2026 and 2033.

Market expansion is underpinned by the rising global demand for animal protein, which is pushing livestock producers to adopt effective parasite-control programs to protect productivity and animal welfare. The Food and Agriculture Organization (FAO) projects that global meat consumption may rise by around 73% between 2010 and 2050, sharply increasing the need for efficient parasite management in cattle, sheep, pigs, and poultry to limit production losses and carcass condemnation rates. At the same time, steady growth in companion animal ownership and pet health spending such as rising veterinary outlays in Europe and North America, supports strong demand for flea, tick, and heartworm preventives, driving long-term penetration of parasiticides into routine preventive care protocols.

Key Market Highlights

Ectoparasiticides type of product segment dominates the market with 52% of the global market share.
The increasing consumer demand for meat and animal byproducts is a key driver for the market growth.
Increased pet ownership and growing pet care expenditure drive the market forward.
North America accounted for 36% of the global market share in 2025.
The increasing incidence of neurological conditions is a key factor driving the veterinary parasiticides market growth.
The increasing prevalence of parasitic infections in both companion animals and livestock is another primary driver for market growth.
The increasing number of pet owners and increased expenditure on pet health are driving demand for veterinary parasiticides.

Key Insights	Details
Veterinary Parasiticides Market Size (2026E)	US$ 10.9 billion
Market Value Forecast (2033F)	US$ 17.1 billion
Projected Growth CAGR (2026–2033)	6.7%
Historical Market Growth (2020–2025)	5.2%

Get Your CustomizationGet Your Customization

Market Dynamics

Drivers - Surging Demand for Animal Protein and Livestock Productivity

A primary growth driver for veterinary parasiticides is the structural rise in demand for animal-source foods and the resulting need to protect herd and flock productivity from parasitic diseases. The FAO has highlighted that global meat consumption could increase by nearly 73% by 2050, requiring more intensive and efficient livestock production systems worldwide. Parasitic infections especially gastrointestinal nematodes, liver flukes, and ticks cause billions of dollars in annual losses by reducing weight gain, feed conversion, fertility, and milk yield. Economic analyses indicate that parasitism can account for nearly 18% of total farm losses in cattle, including reductions of over 1 liter of milk per cow per day and tens of pounds of carcass weight per animal when left untreated. These productivity penalties make regular use of endoparasiticides and endectocides an economically rational investment for producers, thereby supporting sustained demand for veterinary parasiticides across beef, dairy, and small ruminant operations.

Humanization of Companion Animals and Preventive Pet Healthcare

The second major demand engine is the rapid humanization of pets and increased willingness of owners to spend on preventive healthcare, including premium flea, tick, and heartworm control products. Surveys based on American Pet Products Association (APPA) data show that about 94 million U.S. households over 70% of homes now own a pet, up significantly from roughly 82 million pet-owning households earlier in the decade, indicating an expanding base of dogs and cats under regular veterinary care. In parallel, data compiled from U.K. markets indicate pet owners spent about £6.3 billion on veterinary and related services in 2024, with vet service prices having risen by more than 60% since 2016, reflecting both higher intensity and sophistication of care. This environment encourages routine, year-round parasite prevention, particularly as ectoparasites and vector-borne diseases (e.g., tick-borne pathogens) remain common in many geographies, with studies in East and Southeast Asia showing ectoparasite exposure in over 40% of dogs and about 30% of cats. Collectively, these trends underpin growing sales of broad-spectrum parasiticides for companion animals.

Restraints - Antiparasitic Resistance and Stewardship Pressures

Anthelmintic and ectoparasiticide resistance is an emerging restraint on the veterinary parasiticides market, prompting regulators and veterinarians to advocate more prudent, targeted use of these products. The U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA CVM) have implemented the Antiparasitic Resistance Management Strategy (ARMS), emphasizing education, research, and regulatory initiatives to slow resistance development in grazing livestock species. In Europe, the European Medicines Agency (EMA) has issued detailed guidance on responsible use of antiparasitic veterinary medicinal products, recommending that treatments be reserved for situations where medical or epidemiological justification exists rather than applying blanket metaphylactic programs. These stewardship initiatives, while essential for long-term drug efficacy, can temper volume growth in some high-use segments and encourage adoption of integrated parasite-management practices that may reduce reliance on frequent chemotherapeutic interventions.

Opportunities - Broad-Spectrum Combination Products and Next-Generation Formulations

One of the most attractive growth opportunities lies in the development of broad-spectrum, convenient combination products that cover multiple internal and external parasites in a single dose. Recent innovations from leading companies demonstrate strong momentum in this direction: Zoetis secured a new FDA label indication in 2025 for Simparica Trio, making it the only canine combination parasiticide indicated to prevent flea tapeworm infections by killing vector fleas before transmission, and the product has already been used by more than 15 million dogs within five years of its initial approval. Elanco Animal Health obtained FDA approval for Credelio Quattro, a canine parasiticide designed to protect against fleas, ticks, heartworm, roundworms, hookworms and three tapeworm species, with commercial launch planned in early 2025. Similarly, Boehringer Ingelheim introduced NexGard COMBO for cats, a topical solution that provides first-of-its-kind broad-spectrum protection against fleas, ticks, heartworm disease, roundworms, hookworms and tapeworms in a single monthly application. As veterinarians and pet owners increasingly favor simplified dosing and comprehensive protection, demand for such endectocidal and combination products is expected to outpace traditional single-target therapies.

Category-wise Analysis

Animal Type Insights

The production animal segment is the leading animal-type segment, accounting for about 58% of the veterinary parasiticides market in 2025, supported by its central role in safeguarding livestock productivity and food security. Producers of beef and dairy cattle, small ruminants, and pigs face substantial economic losses from internal and external parasites: global analyses estimate that gastrointestinal nematodes and ticks alone cause billions of US dollars in annual losses to beef cattle producers through reduced weight gain, fertility, and carcass quality. Farm-level studies suggest that parasitic infections can contribute nearly 18% of total productivity losses, with impacts such as around 1.16 liters per day less milk, organ condemnations above 10%, and tens of pounds of weight shortfall per animal when infestations are not properly controlled. These data drive strong adoption of endoparasiticides and endectocides in intensive and semi-intensive systems worldwide. At the same time, the companion animal segment is expected to be the fastest-growing animal-type segment through 2032, as the number of pet-owning households and spending per pet rise sharply in regions such as North America, Europe, and parts of Asia, fueling demand for high-value flea, tick, and heartworm preventives.

Route of Administration Insights

In terms of route of administration, topical formulations currently account for a large share of use, especially in production animals and some companion animal applications, owing to their practicality in treating large groups and their longstanding role in controlling external parasites. Veterinary references highlight that a diverse array of topical formulations such as pour-ons, dips, and jetting fluids are widely used in food animals to manage ticks, lice, and other ectoparasites, often formulated as suspension or emulsifiable concentrates to facilitate large-scale application. However, pharmacokinetic studies of macrocyclic lactones indicate that injectable routes can deliver higher and more consistent systemic concentrations than oral or pour-on routes, improving efficacy against internal parasites in ruminants. In companion animals, the oral route particularly palatable chewable tablets have become the fastest-growing mode of administration, as monthly chewable products provide convenient, owner-friendly delivery of broad-spectrum protection against fleas, ticks, intestinal worms, and heartworm disease. This combination of improved compliance, strong clinical efficacy, and favorable safety profiles is expected to sustain higher growth for oral and injectable parasiticides relative to some legacy topical-only products over the forecast period.

Request Free sampleRequest Free sample

Regional Insights

North America Veterinary Parasiticides Market Trends and Insights

North America is the leading regional market, with the U.S. and Canada together accounting for an estimated 35% share of global veterinary parasiticide revenues in 2026, underpinned by high levels of pet ownership, advanced livestock industries, and robust veterinary infrastructure. Data based on APPA surveys indicate that about 94 million U.S. households own at least one pet, representing roughly 71% of all households, and dog and cat populations continue to rise, supporting sustained demand for prescription and over-the-counter flea, tick, and heartworm preventives. Companion animal owners in the region show a strong preference for premium, broad-spectrum products, particularly oral chewables and long-acting formulations, which contributes to higher average spending per animal on parasite control and supports the leadership of major brands from companies such as Zoetis, Elanco, Boehringer Ingelheim, and Merck Animal Health.

The region also benefits from a mature regulatory framework and active innovation ecosystem. The FDA CVM plays a central role in approving and monitoring animal drugs, including antiparasitics, and has recently issued targeted guidance on demonstrating effectiveness for canine heartworm preventives, aligning trial designs with current epidemiological and diagnostic realities. Topical ectoparasiticides have historically fallen under EPA oversight, but a joint EPA–FDA proposal to shift certain systemic topicals to FDA CVM reflects increased regulatory scrutiny and a science-based reassessment of product classification. These dynamics, along with antiparasitic resistance-management initiatives such as ARMS, incentivize ongoing R&D investment, lifecycle management, and pharmacovigilance, ensuring that North America remains the launchpad for many next-generation parasiticides and combination products.

Asia Pacific Veterinary Parasiticides Market Trends and Insights

The Asia Pacific region is expected to be the fastest-growing veterinary parasiticides market through 2032, driven by rapid expansion of livestock production, urbanization, and rising ownership of companion animals across China, India, Japan, and ASEAN economies. FAO modeling indicates that much of the incremental global demand for animal-source protein to 2030 will come from Asia, particularly in poultry and pork, requiring substantial improvements in animal health, productivity, and biosecurity to meet domestic and export requirements. Climatic conditions especially in tropical and subtropical zones favor high burdens of ectoparasites such as ticks and fleas, as well as internal parasites, with multi-country surveys in East and Southeast Asia reporting ectoparasite exposure in over 40% of dogs and around 30% of cats, and tick infestations above 60% in certain settings. These burdens pose not only economic threats to farmers but also zoonotic risks to human populations, reinforcing the need for effective parasite control in both production and companion animals.

Parallel growth in pet ownership, formation of middle-class households, and expansion of private veterinary clinics in urban centers across China, India, and Southeast Asia are also strengthening demand for small animal parasiticides, particularly modern oral and topical formulations that are aligned with international standards. Non-profit organizations and One Health programs have highlighted that parasitic infections can reduce dairy yields by 15–20% and contribute significantly to farm-level income losses, underscoring the value proposition of investing in preventive control measures and farmer education. As governments and industry stakeholders in Asia Pacific continue to upgrade veterinary services, implement disease-control programs, and harmonize regulatory frameworks with global norms, the region is emerging as a critical growth engine for global veterinary parasiticide manufacturers, with ample room for penetration into both high-intensity commercial farms and underserved rural settings.

Competitive Landscape

The leading competitors in the veterinary parasiticides market are primarily evaluated based on their product or service offerings, their financial statements, developments and the approaches implemented. Also, the key companies employ crucial strategies like partnership deals, mergers and acquisitions, and business expansion deals to strengthen their hold on a particular region or a particular service offering.

Key Developments:

April 2025: Zoetis received FDA approval for a new label indication for Simparica Trio, expanding its use to prevent Dipylidium caninum (flea tapeworm) infections by killing vector fleas before transmission, reinforcing the product’s status as a leading combination parasiticide for dogs.
November 2024: Elanco Animal Health obtained FDA approval for Credelio Quattro, the first canine parasiticide in the U.S. designed to protect against fleas, ticks, heartworms, roundworms, hookworms, and three tapeworm species, with commercial launch planned for 2025.
May 2024, Petmedica introduced Atrevia 360, a novel chewable medication for dogs that provides a three-month protection against fleas, ticks, and mites and also offers one-month protection against roundworms, lungworms, and heartworms.
March 2024, A novel species of flatworm was identified in California, United States, and it poses a significant risk of fatality for canines. The flatworm parasite Heterobilharzia americana is commonly known as the liver fluke.

Companies Covered in Veterinary Parasiticides Market

Zoetis
Boehringer Ingelheim
Merck & Co. Inc.
Dechra Pharmaceuticals Plc.
Elanco Animal Health
Ceva Sante Animale
Virbac
Biogénesis Bagó
Vetoquinol
Himalaya Wellness
Others

Frequently Asked Questions

The global veterinary parasiticides market size is expected to reach about US$ 10.9 billion in 2026.

Rising global animal protein consumption increases need for healthier livestock, while growing pet humanization drives demand for routine flea, tick, and parasite prevention.

North America leads the veterinary parasiticides market due to high pet ownership, intensive livestock farming, strong veterinary infrastructure, and early adoption of innovative treatments.

Developing broad-spectrum combination parasiticides offering single-dose protection against internal and external parasites presents major opportunities, especially in expanding Asia Pacific and Latin America markets.

Zoetis, Boehringer Ingelheim, Merck & Co. Inc., Dechra Pharmaceuticals Plc., Elanco Animal Health, are some of the major key, companies in the market.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Veterinary Parasiticides Market Size (2026E)

US$ 10.9 billion

Market Value Forecast (2033F)

US$ 17.1 billion

Projected Growth CAGR (2026–2033)

6.7%

Historical Market Growth (2020–2025)

5.2%

Executive Summary
1. Global Veterinary Parasiticides Market Snapshot 2026 and 2033
2. Market Opportunity Assessment, 2026-2033, US$ Bn
3. Key Market Trends
4. Industry Developments and Key Market Events
5. Demand Side and Supply-Side Analysis
6. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definitions
2. Market Dynamics
  1. Driver
  2. Restraint
  3. Opportunities
  4. Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. Forecast Factors – Relevance and Impact
5. COVID-19 Impact Assessment
Value Added Insights
1. Value Chain analysis
2. Key Market Players
3. Product Adoption Analysis
4. Key Promotional Strategies by key players
5. PESTLE Analysis
6. Porter's Five Forces Analysis
7. Regulatory and Technology Landscape
Global Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Global Veterinary Parasiticides Market Outlook: Animal Type
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Animal Type, 2020-2025
  3. Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
    1. Production Animal
    2. Companion Animal
  4. Market Attractiveness Analysis: Animal Type
3. Global Veterinary Parasiticides Market Outlook: Product
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Product, 2020-2025
  3. Market Size (US$ Bn) Forecast, by Product, 2026-2033
    1. Ectoparasiticides
    2. Endoparasiticides
    3. Endectocides
  4. Market Attractiveness Analysis: Product
4. Global Veterinary Parasiticides Market Outlook: Route of Administration
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Route of Administration, 2020-2025
  3. Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
    1. Oral
    2. Injectable
    3. Topical
  4. Market Attractiveness Analysis: Route of Administration
Global Veterinary Parasiticides Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
3. Market Size (US$ Bn) Forecast by Region, 2026-2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia & Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. U.S.
  2. Canada
3. North America Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
  1. Production Animal
  2. Companion Animal
4. North America Market Size (US$ Bn) Forecast, by Product, 2026-2033
  1. Ectoparasiticides
  2. Endoparasiticides
  3. Endectocides
5. North America Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Injectable
  3. Topical
Europe Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. Germany
  2. Italy
  3. France
  4. U.K.
  5. Spain
  6. Russia
  7. Rest of Europe
3. Europe Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
  1. Production Animal
  2. Companion Animal
4. Europe Market Size (US$ Bn) Forecast, by Product, 2026-2033
  1. Ectoparasiticides
  2. Endoparasiticides
  3. Endectocides
5. Europe Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Injectable
  3. Topical
East Asia Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. China
  2. Japan
  3. South Korea
3. East Asia Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
  1. Production Animal
  2. Companion Animal
4. East Asia Market Size (US$ Bn) Forecast, by Product, 2026-2033
  1. Ectoparasiticides
  2. Endoparasiticides
  3. Endectocides
5. East Asia Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Injectable
  3. Topical
South Asia & Oceania Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of SAO
3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
  1. Production Animal
  2. Companion Animal
4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product, 2026-2033
  1. Ectoparasiticides
  2. Endoparasiticides
  3. Endectocides
5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Injectable
  3. Topical
Latin America Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. Brazil
  2. Mexico
  3. Rest of LATAM
3. Latin America Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
  1. Production Animal
  2. Companion Animal
4. Latin America Market Size (US$ Bn) Forecast, by Product, 2026-2033
  1. Ectoparasiticides
  2. Endoparasiticides
  3. Endectocides
5. Latin America Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Injectable
  3. Topical
Middle East & Africa Veterinary Parasiticides Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. GCC Countries
  2. South Africa
  3. Northern Africa
  4. Rest of MEA
3. Middle East & Africa Market Size (US$ Bn) Forecast, by Animal Type, 2026-2033
  1. Production Animal
  2. Companion Animal
4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product, 2026-2033
  1. Ectoparasiticides
  2. Endoparasiticides
  3. Endectocides
5. Middle East & Africa Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Injectable
  3. Topical
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping
  2. Competition Dashboard
3. Company Profiles
  1. Zoetis
    1. Company Overview
    2. Product Portfolio/Offerings
    3. Key Financials
    4. SWOT Analysis
    5. Company Strategy and Key Developments
  2. Boehringer Ingelheim
  3. Merck & Co. Inc.
  4. Dechra Pharmaceuticals Plc.
  5. Elanco Animal Health
  6. Ceva Sante Animale
  7. Virbac
  8. Biogénesis Bagó
  9. Vetoquinol
  10. Himalaya Wellness
  11. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Veterinary Parasiticides Market Size, Share, and Growth Forecast 2026 - 2033

Veterinary Parasiticides Market by Animal Type (Production Animal, Companion Animal), by Product (Ectoparasiticides, Endoparasiticides, Endectocides), by Route of Administration (Oral, Injectable, Topical), by Regional Analysis, 2026 - 2033